How about #$%$ all the extra monies on new endeavors that fail? I think most old time geron investors do not want to see the company waste their new found money. That is why blackmarango and others would like to see a buy back or sale of the company. Company is in a better position today than prehold yet is down more than 25 percent ytd. If a partnership announcement with jnj can't get the stock moving what can? The only thing that used to get the stock up was when they needed to do a secondary. Now that they don't need cash why do they need to get people interested in their stock?
most of that money is to pay for trials you can not say that it equals 6 dollars/share
Unfortunately okarma spent like 35 million dollars to acquire the license and geron had a failed phase 2 trial and gave angiochem back the rights. Geron does not own this. It was one of the many wasted adventures by okarma
geron had to HALT its breast cancer trials they also halted their lung cancer trials so while telomerase inhibition may help, imetelstat did not work effectively
you have been here long enough to know that seeing is believing at this point with this company...so many promises so many years so many setbacks. lets see if it can get to $1 billion market cap
pcyc has a 10 billion dollar market cap. how can you honestly say geron is going to dwarf that?
where are the analysts? where were the upgrades after the hold lifted? after the janssen partnership? everyone has gone silent. no pr today after all the prs in the last couple of weeks.
i dont expect the moon, i expect the stock to be higher than the 4 dollar secondary they did and better than down 20% for the year, and THAT is not heightened expectations